Search this blog:    Health  Society  Women



FDA approves flibanserin for hypoactive sexual desire disorder in postmenopausal women

With this approval, flibanserin becomes the first and only treatment of its kind for women younger than 65 years.


View article...


Top stories of the last 30 days